Impact of telephone reminders on posttreatment follow-up among women treated for cervical precancers in Cameroon: A randomized controlled trial

IF 1.2 Q3 OBSTETRICS & GYNECOLOGY
Joseph F. Nkfusai , Simon M. Manga , Kathleen Nulah , Calvin Ngalla , Claude Ngwayu , Charlotte B. Mbuwir , Nicholas Tendongfor , Edie Gregory Halle Ekane , Joël Fokom Domgue
{"title":"Impact of telephone reminders on posttreatment follow-up among women treated for cervical precancers in Cameroon: A randomized controlled trial","authors":"Joseph F. Nkfusai ,&nbsp;Simon M. Manga ,&nbsp;Kathleen Nulah ,&nbsp;Calvin Ngalla ,&nbsp;Claude Ngwayu ,&nbsp;Charlotte B. Mbuwir ,&nbsp;Nicholas Tendongfor ,&nbsp;Edie Gregory Halle Ekane ,&nbsp;Joël Fokom Domgue","doi":"10.1016/j.gore.2025.101745","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Effective management of cervical precancerous lesions requires appropriate posttreatment follow-up. In Cameroon like in many Low-and-Middle-Income Countries (LMICs), most women treated for cervical precancers do not present for posttreatment follow-up. The aim of this study was to investigate if a telephone reminder sent to women about missed follow-up appointment could reduce the proportion of those who fail to attend the recommended follow-up, and to examine the association of telephone reminders with posttreatment follow-up adherence.</div></div><div><h3>Methods</h3><div>We carried out a randomized controlled trial nested within a cohort of women screened and treated for cervical precancer (based on positive VIA/VILI results) in a screen-and-treat cervical cancer prevention program in Cameroon. Women who had met clinical criteria for posttreatment follow-up of cervical precancer and did not attend the follow-up appointment within 3 years of precancer treatment were randomly selected and allocated in a 1:1 ratio to the intervention group (receiving a telephone call and text message reminder in addition to the counselling done at the clinic after precancer treatment) and the control group (no telephone reminder after the in-clinic counselling following precancer treatment, per standard of care). Women in the intervention group were contacted by phone, reminded on the importance of posttreatment follow-up they had missed, and invited to return to the clinic for follow-up. The telephone calls were followed by a text message to enhance the understanding of the telephone conversation. The rate of posttreatment follow-up in the intervention group was compared to that of the control group six months after the telephone reminders. A logistic regression analysis was carried out to examine the association between telephone reminders and posttreatment follow-up adherence. Statistical significance was set at p &lt; 0.05.</div></div><div><h3>Results</h3><div>Between 2022 and 2023, up to 203 women treated for cervical precancers who failed to return to the hospital for posttreatment follow-up within 3 years of receiving precancer treatment were enrolled in this study. Posttreatment follow-up following the telephone reminders was 25.6 % (22/86) and 6.1 % (6/99) in the intervention and control groups, respectively (p&lt;0.001). In the logistic regression analysis, women who received the telephone reminders were four times [aOR = 3.97, 95 %CI (1.29––12.17), p=0.016)] more likely to return for precancer posttreatment follow-up compared to those who did not receive the telephone reminders. Women treated for low-grade cervical precancerous lesions were over five times [aOR=5.44, 95%CI (1.00   29.63), p = 0.059] more likely to attend posttreatment follow-up compared to those treated for high-grade lesions. HIV status was not associated with adherence to posttreatment follow-up. The overall posttreatment follow-up rate increased significantly (p = 0.0024) from 26.45 % (73/276) at baseline, to 36.59 % (101/276) following the intervention.</div></div><div><h3>Conclusion</h3><div>Telephone reminders of women treated for cervical precancer who missed their posttreatment appointment in screen-and-treat program in Cameroon significantly increased adherence to posttreatment follow-up. Despite these promising findings, the overall rate of missed posttreatment appointment remained high, suggesting that beyond the lack of education, other factors such as cultural, financial and geographic barriers may play a role in the observed poor adherence to posttreatment follow-up in LMICs. Incorporating telephone reminders into the health package of services for cervical precancer prevention in these settings can improve adherence to posttreatment follow-up.</div></div>","PeriodicalId":12873,"journal":{"name":"Gynecologic Oncology Reports","volume":"59 ","pages":"Article 101745"},"PeriodicalIF":1.2000,"publicationDate":"2025-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gynecologic Oncology Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2352578925000700","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Effective management of cervical precancerous lesions requires appropriate posttreatment follow-up. In Cameroon like in many Low-and-Middle-Income Countries (LMICs), most women treated for cervical precancers do not present for posttreatment follow-up. The aim of this study was to investigate if a telephone reminder sent to women about missed follow-up appointment could reduce the proportion of those who fail to attend the recommended follow-up, and to examine the association of telephone reminders with posttreatment follow-up adherence.

Methods

We carried out a randomized controlled trial nested within a cohort of women screened and treated for cervical precancer (based on positive VIA/VILI results) in a screen-and-treat cervical cancer prevention program in Cameroon. Women who had met clinical criteria for posttreatment follow-up of cervical precancer and did not attend the follow-up appointment within 3 years of precancer treatment were randomly selected and allocated in a 1:1 ratio to the intervention group (receiving a telephone call and text message reminder in addition to the counselling done at the clinic after precancer treatment) and the control group (no telephone reminder after the in-clinic counselling following precancer treatment, per standard of care). Women in the intervention group were contacted by phone, reminded on the importance of posttreatment follow-up they had missed, and invited to return to the clinic for follow-up. The telephone calls were followed by a text message to enhance the understanding of the telephone conversation. The rate of posttreatment follow-up in the intervention group was compared to that of the control group six months after the telephone reminders. A logistic regression analysis was carried out to examine the association between telephone reminders and posttreatment follow-up adherence. Statistical significance was set at p < 0.05.

Results

Between 2022 and 2023, up to 203 women treated for cervical precancers who failed to return to the hospital for posttreatment follow-up within 3 years of receiving precancer treatment were enrolled in this study. Posttreatment follow-up following the telephone reminders was 25.6 % (22/86) and 6.1 % (6/99) in the intervention and control groups, respectively (p<0.001). In the logistic regression analysis, women who received the telephone reminders were four times [aOR = 3.97, 95 %CI (1.29––12.17), p=0.016)] more likely to return for precancer posttreatment follow-up compared to those who did not receive the telephone reminders. Women treated for low-grade cervical precancerous lesions were over five times [aOR=5.44, 95%CI (1.00   29.63), p = 0.059] more likely to attend posttreatment follow-up compared to those treated for high-grade lesions. HIV status was not associated with adherence to posttreatment follow-up. The overall posttreatment follow-up rate increased significantly (p = 0.0024) from 26.45 % (73/276) at baseline, to 36.59 % (101/276) following the intervention.

Conclusion

Telephone reminders of women treated for cervical precancer who missed their posttreatment appointment in screen-and-treat program in Cameroon significantly increased adherence to posttreatment follow-up. Despite these promising findings, the overall rate of missed posttreatment appointment remained high, suggesting that beyond the lack of education, other factors such as cultural, financial and geographic barriers may play a role in the observed poor adherence to posttreatment follow-up in LMICs. Incorporating telephone reminders into the health package of services for cervical precancer prevention in these settings can improve adherence to posttreatment follow-up.
电话提醒对喀麦隆宫颈癌前病变妇女治疗后随访的影响:一项随机对照试验
背景:宫颈癌前病变的有效治疗需要适当的治疗后随访。与许多低收入和中等收入国家一样,在喀麦隆,大多数接受宫颈癌前病变治疗的妇女没有参加治疗后随访。本研究的目的是调查电话提醒女性错过随访预约是否可以减少未参加推荐随访的女性比例,并检查电话提醒与治疗后随访依从性的关系。方法我们在喀麦隆的宫颈癌预防筛查和治疗项目中,对接受宫颈癌前病变筛查和治疗的妇女(基于VIA/VILI阳性结果)进行了一项随机对照试验。随机选择符合宫颈癌前病变治疗后随访临床标准且在癌前治疗3年内未参加随访预约的妇女,按1:1的比例分配到干预组(癌前治疗后在诊所进行咨询的同时接受电话和短信提醒)和对照组(癌前治疗后在诊所进行咨询后不接受电话提醒)。按护理标准)。通过电话联系干预组的妇女,提醒她们错过的治疗后随访的重要性,并邀请她们返回诊所进行随访。电话之后会有一条短信,以加强对电话交谈的理解。在电话提醒6个月后,比较干预组与对照组的治疗后随访率。采用logistic回归分析检验电话提醒与治疗后随访依从性之间的关系。p <;0.05.结果在2022年至2023年期间,多达203名接受宫颈癌前病变治疗的妇女在接受癌前病变治疗后3年内未能返回医院进行治疗后随访。干预组和对照组的电话提醒随访率分别为25.6%(22/86)和6.1% (6/99)(p<0.001)。在logistic回归分析中,接受电话提醒的女性在癌前治疗后随访时复诊的可能性是未接受电话提醒的女性的4倍[aOR = 3.97, 95% CI(1.29—12.17),p=0.016]。接受低级别宫颈癌前病变治疗的妇女参加治疗后随访的可能性是接受高级别病变治疗的妇女的5倍以上[aOR=5.44, 95%CI (1.00 29.63), p = 0.059]。HIV感染状况与治疗后随访的依从性无关。总体治疗后随访率(p = 0.0024)从基线时的26.45%(73/276)显著增加到干预后的36.59%(101/276)。结论喀麦隆宫颈癌前病变妇女在筛查治疗计划中错过治疗后预约的电话提醒可显著提高治疗后随访的依从性。尽管有这些令人鼓舞的发现,但错过治疗后预约的总体比率仍然很高,这表明除了缺乏教育之外,文化、经济和地理障碍等其他因素可能在中低收入国家观察到的治疗后随访依从性差方面发挥作用。在这些环境中,将电话提醒纳入宫颈癌前期预防保健服务包,可提高对治疗后随访的依从性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Gynecologic Oncology Reports
Gynecologic Oncology Reports OBSTETRICS & GYNECOLOGY-
CiteScore
2.00
自引率
0.00%
发文量
183
审稿时长
41 days
期刊介绍: Gynecologic Oncology Reports is an online-only, open access journal devoted to the rapid publication of narrative review articles, survey articles, case reports, case series, letters to the editor regarding previously published manuscripts and other short communications in the field of gynecologic oncology. The journal will consider papers that concern tumors of the female reproductive tract, with originality, quality, and clarity the chief criteria of acceptance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信